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Background: There is a lack of systematic and comprehensive evaluations whether food intakes lower or increase
risk of chronic diseases. In this network meta-analysis of prospective cohort studies, we aim to evaluate the effects
of different foods on risk of chronic diseases.
Methods/design: We will search PubMed and EMBASE. This will be supplemented by a hand search and author
contacts. Citations, abstracts, and relevant papers will be screened for eligibility by two reviewers independently.
Prospective cohort studies will be included if they meet the following criteria: (1) evaluate the association of single
food or food groups with all-cause mortality, cardiovascular diseases (incidence and mortality), cancer (incidence
and mortality) or risk of type 2 diabetes. The following food groups will be evaluated: whole grains, refined grains,
vegetables, fruits, nuts, legumes, eggs, dairy products, fish, red meat, processed meat and sugar-sweetened
beverages; (2) include participants ≥18 years of age; and (3) study population were free of outcome(s) of interest at
the onset of the study. To assess study quality, we will extract the following characteristics: study size, duration of
follow-up, dietary assessment method, assessment of outcome and adjustment factors. If the identified studies
appear sufficiently similar within and across the different comparisons between pairs of food groups, we will
estimate summary-relative effects using random effects network meta-analysis. Subgroup and meta-regression
analyses will be performed stratified by different follow-up cut-points, geographical region and sex.
Discussion: This is a presentation of the study protocol only. Results and conclusions are pending completion of
this study. Our systematic review will be of great value to national and international authorities for evidence-based
nutritional recommendation/guidelines, regarding the implementation of food-based dietary guidelines for prevention
of chronic diseases. Moreover, our results can be implemented to develop new diet quality indices/scores.
Systematic review registration: PROSPERO CRD42016037069
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Globally in 2013, the total number of deaths across all age
groups rose to approximately 55 million. Seventy percent
of these deaths were caused by non-communicable dis-
eases, with cardiovascular or circulatory diseases being
responsible for 32 % of the fatalities (15 % by ischemic* Correspondence: lukas.schwingshackl@dife.de
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2 diabetes) followed by cancer mortality with 15 % [1].
In nutrition research, randomized controlled trials
often address short-term interventions (evaluating many
dietary hypotheses) in high risk groups with intermediate
outcomes. There are only a few long-term intervention
studies in nutrition research and all of them evaluating
many dietary hypotheses in one trial [2–4]. Therefore, in
nutrition research, well-designed prospective cohort
studies are the main source of evidence to address decade
long exposures populations with hard clinical endpointsle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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60–75 % of coronary and 36 % of cancer incidents
can be explained by lifestyle factors such as unhealthy
diets, overweight, obesity, physical inactivity, smoking
and excessive alcohol intake [6]. According to the Global
Burden of Disease Group in 2012, unhealthy diet is the
leading risk factor for death and disability [7]. A high
intake of alcohol, red meat, processed meat, sugar-
sweetened beverages, collectively accounted for 10 % of
global disability-adjusted life years in 2010 [7]. In addition,
a diet low in fruits, vegetables, milk, nuts, seeds, seafood
and whole grains might also contribute to risk of death
and chronic diseases.
Previous pairwise meta-analyses of cohort studies
showed that certain food groups such as whole grains,
vegetables and fruits were associated with reduced risk
of coronary heart disease, cancer, and type 2 diabetes
[8–10], whereas red meat or sugar-sweetened beverages
were associated with increased risk [8–10]. To the best
of our knowledge, no systematic review and meta-analysis
has compared simultaneously the effects of multiple
dietary factors on all-cause mortality, cardiovascular
disease, cancer disease and risk of type 2 diabetes.
One important question that remains to be answered
is which foods are associated with the most pronounced
risk reduction.
Therefore our objective is to compare the impact of
different foods on the risk of all-cause mortality, cardio-
vascular disease, cancer and type 2 diabetes using pro-
spective cohort studies. We also aim to obtain a useful
relative ranking of the different foods with respect to the
prevention of chronic disease.
Methods and design
The review was registered in PROSPERO International
Prospective Register of Systematic Reviews (http://www.crd.
york.ac.uk/PROSPERO/display_record.asp?ID=CRD4201
6037069, identifier CRD42016037069). The present system-
atic review protocol was planned, conducted, and reported
in adherence to standards of quality for reporting system-
atic review and network meta-analysis protocols [11–14]
(Additional file 1).
Eligibility criteria
Studies will be included in the meta-analysis if they meet
all of the following criteria.
Types of studies
Only studies with a prospective cohort design (including
prospective cohort studies, nested case-control studies,
randomized controlled trials, case-cohort studies) that
are peer-reviewed and available in full-text will be eligible
for the present systematic review.Types of participants
Participants aged 18 or older will be eligible. Prospective
studies based on children, adolescent or pregnant
women will be excluded. The sample included in final
analysis had to be free of the outcome(s) (cardiovascular
disease and/or, cancer, and/or type 2 diabetes) of interest
at the onset of the study.
Exposure
The impact of the following twelve food groups will be
evaluated: whole grains/cereals, refined grains/cereals,
vegetables, fruits, nuts, legumes, eggs, dairy products
(milk, cheese, yogurt), fish, red meat, processed meat and
sugar-sweetened beverages. The focus will be on these 12
food groups since most diet quality indices/score were
based on these [15–17].
The assessment of dietary intake is based on multidi-
mensional exposures and in free-living populations these
measurements are often not accurate. The most com-
monly used techniques for assessing food and drink con-
sumption are food frequency questionnaires, dietary
record, dietary history, or 24-h recall. We will include any
definition of high (e.g. third tertile, or consumers) vs. low/
reference (i.e. first tertile, or non-consumers) intake cat-
egories and we intend to account for the possible impact
of the different definitions in additional analyses (see the
Exploration of heterogeneity and inconsistency section).
The use of cohort studies in this systematic review
makes the evaluation of transitivity challenging since the
idea of ‘joint randomizability’ is not plausible in this
setting [18]. However, we will assess whether transitivity
is likely to hold prior to the data synthesis following the
strategy described in the section Assessment of the tran-
sitivity assumption.
Geometry of the network
We do not expect to identify studies directly comparing
two or more different food groups. Nevertheless, if such
studies that meet the eligibility criteria will be identified,
we will include them in the network. Figure 1 shows the
network of all possible pairwise comparisons between
the eligible dietary factors, and Fig. 2 shows a ‘star net-
work’ between the different dietary factors and control;
we expect that the structure of our final network will be
close to Fig. 2.
Outcome measures
We will consider the following outcomes:
 Primary outcome
1. All-cause mortality; the following outcome
assessments will be considered: death registers,
record linkage, death certificates, physician
records, autopsy data.
Fig. 1 Network of all possible pairwise comparisons between the eligible dietary factors
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1. Cardiovascular disease (incidence); defined
accordingly: myocardial infarction, coronary heart
disease, coronary artery disease (angina pectoris,
myocardial infarction), stroke (haemorrhagic,
ischemic), and heart failure. The following
outcome assessments will be considered: record
linkage (ICD codes), accepted clinical criteria,
death registers, death certificates.
2. Cancer (incidence); record linkage (ICD codes),
cancer registry data, death certificates, the
diagnosis of cancer should be always supportedFig. 2 Star network of the comparisons between every eligible dietary factor andby pathological examination of tissues. We will
include cancer incidence for specific cancer sides
(breast, colorectal, prostate, stomach).
3. Type 2 diabetes: the diagnosis should have been
established using the standard criteria valid at the
time of the beginning of the prospective study.
The following outcome assessments will be
considered: record linkage, National register
confirmed by medical certificates, self-report of
physician diagnosis, confirmed self-report of
physician diagnosis, identified from register of
persons receiving drug imbursement.control
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The search strategy was developed by LS, SS and HB,
and will be performed by LS, AB, MSM and KI, and dif-
ferences resolved by discussion with a third reviewer
(HB). We will conduct searches in PubMed (from 1966)
and EMBASE (from 1980). We will search for articles of
original research by using the following search terms:
#1 food and beverages [MeSH Terms]
#2 food*[tiab] OR whole grain*[tiab] OR refined
grain*[tiab] OR cereal*[tiab] OR pasta*[tiab] OR
rice*[tiab] OR potato*[tiab] OR vegetable*[tiab] OR
fruit*[tiab] OR nut*[tiab] OR legume*[tiab] OR
bean*[tiab] OR egg*[tiab] OR dairy[tiab] OR
dairies[tiab] OR milk[tiab] OR yogurt[tiab] OR
cheese[tiab] OR fish[tiab] OR seafood[tiab] OR
meat[tiab] OR processed meat[tiab] OR sugar
sweetened beverage*[tiab]
#3 mortality OR incidence OR cardiovascular OR
coronary OR stroke OR cancer OR neoplasm OR
neoplastic disease OR diabetes OR vascular OR
myocardial infarction
#4 prospective OR follow-up OR cohort OR
longitudinal
#5 (#1 OR #2) AND #3 AND #4
Moreover, the reference lists from the retrieved arti-
cles; systematic reviews and meta-analyses will be
checked to search for further relevant studies (umbrella
review of systematic review and meta-analyses). There
will be no restrictions on language or publication year.
Studies published in languages other than English will
be translated by international scientists in our institute.
Study selection process
Two reviewers will independently screen titles and
abstracts of all the retrieved bibliographic records. Full
texts of all potentially eligible records passing the title
and abstract screening level will be retrieved and exam-
ined independently by two reviewers (for each database)
with the abovementioned eligibility criteria/exclusion
criteria [19, 20]. Disagreements will be resolved by
consensus or adjudication of another reviewer. A flow
diagram will outline the study selection process and rea-
sons for exclusions (full-text). When a study was pub-
lished in duplicate, we will include the version containing
the most comprehensive information (latest information
in the case of follow-up studies).
Data extraction
After determination of the study selection, two reviewers
will extract independently the following characteristics:
the first author’s last name, year of publication, study
origin, cohort name, sample size, number of cases, ageat entry, sex, study length (follow-up in years), outcome,
outcome assessment, assessment of diet, quantity of diet,
risk estimate (most adjusted measures) (hazard ratios
(HR), risk ratios (RR) or odds ratios (OR) with their
corresponding 95 % confidence intervals (CIs)) and ad-
justment factors using our own checklist (piloting of the
tool based on three studies will be performed).
When a study provides several risk estimates, the
multivariate adjusted model will be chosen. If only sep-
arate risk estimates for male and female participants will
be available in one study, data will be pooled and treated
as one study.
Risk of bias assessment
To assess the risk of bias of the cohort studies, we will as-
sess ascertainment of exposure (e.g. validated, calibrated
FFQ, 24 h recall/diet history/diet records for multiple days
will be judged as low risk of bias; whereas un-validated
FFQ, single 24 h recall/diet records/diet history will be
judged as high risk of bias studies), assessment of outcome
(e.g. record linkage according ICD codes, accepted clinical
criteria, independent or blind assessment will be judged as
low risk of bias; whereas self-reported not validated
assessment will be judged as high risk of bias studies), ad-
equacy of follow-up depending on the outcome (e.g. strati-
fied by the median duration of follow-up: e.g. ≥10 years
for CVD will be judged as low risk of bias; whereas
<10 years for CVD will be judged as high risk of bias), and
adjusted basic model and outcome relevant adjustments
(e.g. adjustment for the most important factors: sex, age,
education, smoking and physical activity, BMI will be
judged as low risk of bias studies; whereas low number of
adjustments will be judged as high risk of bias), based on
our own developed tool [21]. Studies will be classified as
being at low risk of bias in general only if none of the
domains established a high risk of bias, and at moderate
overall risk of bias if they were at high risk for one domain
only. In all other cases, studies were classified as being
overall at high risk of bias.
Dealing with missing data
We will try to obtain relevant missing data from authors
of the included cohort studies (by e-mail). If we will not
be able to obtain the missing data we will exclude the
cohort from the network meta-analysis (NMA). We do
not expect high missing data rate, since this phenomenon
is not common in meta-analysis of observational studies
[15, 18, 22].
Evaluation of synthesis assumptions and statistical
analysis
Description of the available data
We will generate descriptive statistics for study and
population characteristics describing the available data
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up, outcome relevant baseline risk factors, etc.) for each
pairwise comparison. We will present the available direct
comparisons between different food groups and control
using a network diagram for each outcome [23]. The size
of the nodes will be proportional to the sample size/
number of cases exposed to each dietary factor and the
thickness of the lines proportional to the inverse vari-
ance of the respective direct relative effects. We will also
use the contribution matrix to identify the direct com-
parisons with greater influence in the network relative
effects [23, 24].Standard pairwise meta-analyses
We will perform three types of analysis:
1. High vs. low intake meta-analyses: summary risk will
be estimated for high versus low intake of single
food or food groups and risk of chronic diseases by
applying random effect models.
2. Dose-response meta-analyses: we will investigate the
association between intake of dietary factors as a
continuous variable and risk of chronic diseases, by
performing a dose-response meta-analysis as
described by Orsini et al. and Greenland and
Longnecker [25, 26]. This method requires for at
least three exposure categories: the quantified
exposure value and the RRs with the respective
95 % CI, as well as the number of cases and
person-years. If studies did not report on distribution
of person-years in single categories, but provided
information on number of cases and total person-
years/ or number of total participants plus follow-up
period, we will estimate the missing information as
previously described [27, 28].
3. Non-linear dose-response relation: in addition, we
will explore whether there is indication for a non-
linear dose-response relation between dietary factors
and chronic diseases. We will perform cubic spline
regression models and evaluate non-linearity by
using a likelihood ratio test [29].
To explore heterogeneity between studies, we will use
the Q test and the I2 statistic (with a value of I2 > 50 %
considered to represent potentially important heterogen-
eity [30]). In addition, to identify potential sources of
heterogeneity, we will stratify the meta-analysis by sub-
groups (age, length of follow-up, dietary assessment
method) and use meta-regression analysis.Assessment of the transitivity assumption
Transitivity is the fundamental assumption of indirect
comparisons and network meta-analysis, and its violationthreatens the validity of the findings obtained from a
network of studies. Our inference about the plausibility of
transitivity will be based on the following criteria:
 We will assess the similarity and comparability of
each dietary factor as well as for the control/
reference groups when they appear in different
studies. For example, we will assess whether
discrepancies in amount of intake or definition of
exposure of the same foods across studies are likely
to render some nodes in the network intransitive.
 We will assess whether the potential effect modifiers
(see the Data Extraction section) are similarly
distributed across the available direct comparisons
in the network.
Network meta-analysis
If the identified studies appear to be sufficiently similar
with respect to the effect modifiers and transitivity is
likely be plausible, we will perform a random effects
network meta-analysis for each outcome to estimate all
possible pairwise relative effects and obtain a clinically
meaningful relative ranking of the different food groups.
We will use contrast-level data (HRs, RRs or ORs separ-
ately) as we do not expect arm-level data to be available.
We will account for the correlation in studies with mul-
tiple dietary groups when the required data are available
to obtain the covariance of the effect sizes from such
studies. If we will not be able to obtain these covari-
ances, we will treat the effect sizes from these studies as
independent and we will assume different correlation
values in a sensitivity analysis. We will present summary
HRs, RRs or ORs in a league table. We will also estimate
the relative ranking of the different food groups for each
outcome using the distribution of the ranking probabil-
ities and the surface under the cumulative ranking
curves (SUCRA) [31]. For each outcome, we will assume
a common network-specific heterogeneity parameter
and we will estimate the predictive intervals to assess how
much this heterogeneity affects the relative effects with
respect to the additional uncertainty anticipated in future
studies [32].
Assessment of inconsistency
To evaluate the presence of statistical inconsistency (i.e.
disagreement between the different sources of evidence)
in the data we will employ both local and global ap-
proaches [33]. Specifically, we will use the loop-specific
approach [34] to detect loops of evidence that might
present important inconsistency as well as the node-
splitting approach [35] to detect comparisons for which
direct estimates disagree with indirect evidence from the
entire network. Global methods investigate the presence
of inconsistency jointly from all possible sources in the
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treatment interaction model and the I2 statistic [36, 37].
Exploration of heterogeneity and inconsistency
In the presence of important heterogeneity and/or incon-
sistency, we will explore the possible sources. If sufficient
data will be available, we will run network meta-regression
analyses to account for differences by duration of follow-
up of the studies, sex, dietary assessment method, level of
physical activity, body mass index, smoking status and
outcome relevant baseline risk factors (e.g. blood pressure,
dyslipidemia).
Small-study effects and publication bias
We will use the comparison-adjusted funnel plot [23] to
assess the presence of small-study effects in the network
and contour-enhanced funnel plots [38] to investigate
whether funnel plot asymmetry is likely to be explained
by publication bias. We will also run network meta-
regression models that account for differences in the rela-
tive effects between smaller and larger studies [39].
Sensitivity analyses
We will assess the sensitivity of results for the primary
outcome by analysing only studies considered being at
low risk of bias.
Implementation and software
We will fit all analyses described in a frequentist frame-
work using Stata [40] (network package [41]), and we
will produce presentation tools with the network graphs
package [42].
Quality of the evidence
We will first use our recently developed NutriGrade-tool
to evaluate and judge the meta-evidence for pairwise
comparisons, which has been especially developed for
nutrition research to address specific requirements for
this research field [21]. Then, to infer about the quality
of evidence from the network meta-analysis will com-
bine our judgment about the direct comparisons with
their contributions in the estimation within the network
as described in Salanti et al. [33].
Discussion
This systematic review and network meta-analysis will
be the first to summarize and compare the effects of dif-
ferent foods or food groups on all-cause mortality, car-
diovascular disease, type 2 diabetes and cancer, using
both direct and indirect evidence. This analysis will
show which foods or food groups, if any, might be the
most promising in the prevention of chronic diseases.
Our systematic review will be of great value to nationaland international authorities for evidence-based nutri-
tional recommendation/guidelines, regarding the pre-
vention of chronic diseases. Moreover, our results can
be implemented to develop new diet quality indices/
scores.
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